Refaja
About Refaja
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Refaja
During the past decade, Refaja conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases
2005-01-01
2012-12-01
Terminated
80
Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer
2004-03-01
2008-09-01
Unknown status
130
TRACT Study: Evaluation of the Value of Routine Thoraco-abdominal CT in Blunt Trauma Patients
2005-06-01
2008-12-01
Completed
1,000
Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis
2007-03-05
2009-05-09
Completed
204
Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
2008-07-01
2012-12-01
Completed
20
The Effects of Blood Pressure Reduction on Cerebral Perfusion and Cognition in the Elderly Population
2009-09-01
2013-12-01
Unknown status
60
In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II
2013-09-01
2014-01-01
Completed
20
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
2013-10-01
2015-04-01
Completed
875
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Refaja"
#1 collaborator was "Cisbio Bioassays" with 1 trials as a collaborator, "Disphar International B.V." with 1 trials as a collaborator, "Dutch Cancer Society" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Leiden University Medical Center" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Refaja
According to Clinical.Site data, the most researched conditions in "Refaja" are
"Abdominal Pain" (1 trials), "Crohn's Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diarrhea" (1 trials) and "Endometrial Cancer" (1 trials). Many other conditions were trialed in "Refaja" in a lesser frequency.
Clinical Trials Intervention Types at Refaja
Most popular intervention types in "Refaja" are "Drug" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Digoxin" (1 trials), "Exenatide (AC2993)" (1 trials), "Insulin glargine" (1 trials), "Placebos" (1 trials) and "Reduced follow-up schedule" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Refaja
The vast majority of trials in "Refaja" are
3 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Refaja
Currently, there are NaN active trials in "Refaja".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Refaja,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Refaja, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".